Leena Menghaney discusses the experience of fighting for provisions in India’s IP legislation to protect health
Leena Menghaney of Médecins Sans Frontières India discusses the battle of Indian activists in fighting for pro-public health intellectual property laws and the ongoing threats to the provisions to protect health in India’s laws. The recording, provided from Community Media Trust, was shot at an open lecture hosted by TAC and MSF at the University […]
TAC congratulates Kenyan activists for their work to combat the 2008 Anti-Counterfeit Act in Kenya. If adopted, the Act would have severely compromised medicine access in Kenya by including vague definitions of counterfeit medicines that could extend to generic medicines. If adopted as written, the act would have allowed authorities to seize generic medicine under […]
Business Day reports on TAC’s appeal to the Supreme Court of Appeal to consider public health in patent dispute http://www.businessday.co.za/Articles/Content.aspx?id=170179
The TAC National Council has resolved to seek admission in a legal dispute between the brand name drug company Aventis Pharma and the generic company Cipla, over a claim of patent infringement on a drug that treats cancer called Docetaxel. SECTION27 will act as attorneys for TAC. This briefing note sets out the background to […]
Will local production of APIs offer the health, development and economic benefits promised by government?
The South African government recently announced plans to manufacture active pharmaceutical ingredients (APIs) in partnership with the Swiss based company Lonza Ltd. APIs are the active ingredients that are used to produce medicines. Medicines also contain inactive ingredients called excipients. South Africa has a relatively large and competitive generic pharmaceutical industry made up of a […]